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After activation, CD4+ helper T (Th) cells differentiate
into distinct effector subsets. Although chemokine
(C-X-C motif) receptor 5-expressing T follicular
helper (Tfh) cells are important in humoral immunity,
their developmental regulation is unclear. Here we
show that Tfh cells had a distinct gene expression
profile and developed in vivo independently of the
Th1 or Th2 cell lineages. Tfh cell generation was reg-
ulated by ICOS ligand (ICOSL) expressed on B cells
and was dependent on interleukin-21 (IL-21), IL-6,
and signal transducer and activator of transcription
3 (STAT3). However, unlike Th17 cells, differentiation
of Tfh cells did not require transforming growth factor
b (TGF-b) or Th17-specific orphan nuclear receptors
RORa and RORg in vivo. Finally, naive T cells acti-
vated in vitro in the presence of IL-21 but not
TGF-b signaling preferentially acquired Tfh gene
expression and promoted germinal-center reactions
in vivo. This study thus demonstrates that Tfh is a
distinct Th cell lineage.
INTRODUCTION
Naive CD4+ helper T (Th) cells, upon encountering their cognate
antigens presented on professional antigen-presenting cells
(APCs), differentiate into effector cells that are characterized
by their distinct cytokine production profiles and immune regula-
tory functions. In addition to Th1 and Th2 cells (Dong and Flavell,
2000), Th17 cells, a third subset of Th cells, have been recently
identified; Th17 cells produce interleukin-17 (IL-17), IL-17F,
and IL-22 and regulate inflammatory responses by tissue cells
(Dong, 2008). Th17 cell differentiation, at least in mouse, is initi-
ated by transforming growth factor b (TGF-b) and IL-6 (Bettelli
et al., 2006; Mangan et al., 2006; Veldhoen et al., 2006a), possi-
bly via regulation of the chromatin remodeling of the Il17-Il17f
locus (Akimzhanov et al., 2007). Whereas IL-6 is necessary for138 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.Th17 cell differentiation (Korn et al., 2007; Yang et al., 2007),
IL-21 was recently reported as an autocrine factor induced
by IL-6 to regulate Th17 cell differentiation (Korn et al., 2007;
Nurieva et al., 2007a; Zhou et al., 2007). On the other hand,
TGF-b signaling has also been clearly demonstrated to mediate
Th17 cell differentiation in vivo (Bettelli et al., 2006;Mangan et al.,
2006; Veldhoen et al., 2006b). Th17 cell development is depen-
dent on signal transducer and activator of transcription
3 (STAT3) (Laurence et al., 2007; Yang et al., 2007), which func-
tions to upregulate the expression of two Th17-specific orphan
nuclear receptors, RORgt and RORa, that ultimately determine
Th17 cell terminal differentiation (Ivanov et al., 2006; Yang
et al., 2008b).
A fundamental function of Th cells is to provide ‘‘help’’ to
B cells and regulate their proliferation and immunoglobulin class
switching, especially in the germinal-center structures. Th1 and
Th2 cells have been shown to regulate B cell responses to
some extent. For example, IFN-g regulates IgG2a production
whereasIL-4 is critical in IgE class switching. However, an addi-
tional Th cell subset called T follicular helper (Tfh) cells are
recently found to be present in germinal centers and are charac-
terized by their expression of chemokine (C-X-C motif) receptor
5 (CXCR5) (Vinuesa et al., 2005b). Although activated T cells may
transiently express CXCR5, Tfh cells appear to have more stable
expression of this chemokine receptor. These cells are thought
to regulate humoral immunity, especially germinal-center reac-
tions. Consistent with this notion, CXCR5 has been shown to
be important for proper T and B cell localization in immune
responses and antibody production (Haynes et al., 2007; Junt
et al., 2005). In addition to CXCR5, other markers have been
also reported for Tfh cells, such as inducible costimulatory
receptor (ICOS), IL-21 cytokine, and Bcl-6 transcription factor.
ICOS was found essential for generation of Tfh cells in vivo
(Akiba et al., 2005). In addition to Th17 cells, IL-21 is also
expressed in Tfh cells and may serve as an important regulator
of humoral responses by Tfh cells. IL-21 directly regulates B cell
proliferation and class switching; IL-21R deficiency results in de-
fective antibody responses and impaired germinal-center forma-
tion (Spolski and Leonard, 2008). On the other hand, sanroque
mice, which have a mutation in a RING-type E3 ubiquitin ligase,
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lupus-like autoimmunity, associated with greatly increased num-
bers of CXCR5+CD4+ T cells and enhanced expression of IL-21
and ICOS (Vinuesa et al., 2005a).
Despite their potential importance in humoral immunity and
immunopathology, the developmental regulation of Tfh cells
and their relationship with other Th cell subsets is unclear, partic-
ularly considering that IL-21 is expressed by both Th17 and Tfh
cells. A previous study revealed that human Tfh cells express
genes distinct from those expressed by Th1 or Th2 cells
(Chtanova et al., 2004). Here we show that mouse Tfh cells
have a divergent gene expression profile from Th1, Th2, and
Th17 cells and developed in vivo independently of these line-
ages. IL-21, IL-6, and STAT3 were critical in the generation of
Tfh cells. Moreover, T cells activated in vitro in the presence of
IL-21 but without TGF-b signaling preferentially acquired Tfh
gene expression and functioned to promote humoral immunity
in vivo. Thus, our data indicate that Tfh cells represent a distinct
Th cell lineage and suggest a reciprocal relationship between the
Tfh and Th17 cell lineages.
RESULTS
Distinct Gene Expression Profile of Tfh Cells
As a first step toward understanding Tfh cell regulation, we com-
pared the gene expression profiles of Th1, Th2, and Th17 cells
differentiated in vitro with in vivo-generated Tfh cells. Taking
advantage of the coexpression of B and T lymphocyte attenuator
(BTLA) by CXCR5+ Tfh cells (Figure S1 available online), we
FACS sorted CD4+CD44hiCXCR5+BTLA+ cells from splenocytes
of C57BL/6 mice 7 days after immunization with keyhole limpet
hemocyanin (KLH). These cells, as well as Th1, Th2, and Th17
cells, were restimulated with anti-CD3 for 4 hr and subjected
to gene-profiling analysis in duplicates via Affimetrix gene chips.
The microarray data were normalized with GC robust multiarray
average (GCRMA) and the genes whose expression was
changed across the Th1, Th2, Th17, and Tfh cells were then se-
lected by a false-discovery rate (FDR) estimation method. Then,
the expression levels of 8350 probe sets showing differential ex-
pressions among the four types of cells were used for hierarchi-
cal clustering, which revealed that Tfh cells have a very distinct
gene expression profile (Figure 1A, Figure S2A).
To confirm the above results, we performed real-time RT-PCR
analysis on multiple subset-specific genes. The data indicate
that Tfh cells did not express the typical markers for Th1 (IFN-g
and T-bet) or Th2 (IL-4 and GATA3) cells (Figure 1B), consistent
with a previous report on human Tfh cells (Chtanova et al., 2004).
Although Tfh cells shared IL-21 expression with Th17 cells,
they did not express IL-17, IL-17F, IL-22, or RORgt (Figure 1B).
Instead, similar to their human counterparts (Chtanova et al.,
2004; Kim et al., 2004), mouse Tfh cells express mRNAs for
CXCR5 as well as Bcl-6 (Figure 1B). In addition, Tfh cells prefer-
entially expressed mRNAs for IL-6R and IL-6st (gp130) and also
upregulated the expression of IL-21R (Figure 1B), suggesting
possible regulation of Tfh cells by IL-6 and IL-21. Moreover, con-
sistent with human Tfh cells (Chtanova et al., 2004) and a recent
report indicating that Tfh cells express programmed death-1
(PD-1) protein (Haynes et al., 2007), PD-1 mRNA was highlyupregulated in Tfh cells compared to other Th cell subsets
(data not shown).
To substantiate the above results, we also measured cytokine
secretion of purified Tfh cells after they were activated ex vivo
with anti-CD3 and anti-CD28 for 24 hr. High expressions of
IL-21 but not IL-4, IL-10, IFN-g, or IL-17 were observed in Tfh
cells (Figure 1C). In addition, purified Tfh cells were activated
with KLH and irradiated splenic APCs. Consistent with above
results, Tfh cells preferentially produced IL-21, but not Th1,
Th2, and Th17 cytokines (Figure S3). Furthermore, intracellular
analysis on CXCR5+ and CXCR5 cells after PMA and ionomycin
restimulation also revealed that Tfh cells did not express IFN-g or
IL-17 (Figure 1D). These results indicate that Tfh cells are distinct
from Th1, Th2, and Th17 cells in their gene expression and
cytokine production.
Naive T Cell Differentiation into Tfh Cells Is Independent
of Th1 and Th2 Cell Lineages
Previous analysis (Chtanova et al., 2004) and our current gene
expression analysis on human andmouse Tfh cells, respectively,
suggested that they are distinct from Th1 and Th2 cells. How-
ever, it was not clear whether generation of Tfh cells is distinct
from Th1 or Th2 cell differentiation. To address this question,
we transferred FACS-sorted naive CD4+ T cells (CXCR5) from
OT-II TCR transgenic mice (CD45.2+, Figure 2A) into C57BL/6
recipients (CD45.1+), followed by immunization with Ova protein
in CFA. Seven days later, we examined splenic CD45.1+ and
CD45.2+ CD4+ T cells and found a substantial increase in the fre-
quency of CXCR5+CD4+ T cells (Figure 2A). Interestingly, treat-
ment of recipient mice with antibodies to IL-4 and IFN-g did
not reduce the proportion of CXCR5+CD4+ T cells (Figure 2A),
suggesting that Tfh cell development is independent of Th1 or
Th2 cell development. In addition, donor CD44hiCXCR5+ and
CD44hiCXCR5 OT-II cells from immunized mice were purified,
and real-time RT-PCR analysis of Tfh-specific genes was per-
formed. CXCR5+ T cells were generated in the presence of
blocking antibodies to IL-4, and IFN-g exhibited gene expression
patterns comparable to those from the control group (Figure 2A),
suggesting that these CXCR5+ cells were indeed Tfh cells.
To substantiate the above finding, we also immunized mice
deficient in IL-4, IFN-g, STAT6, or STAT4 and their appropriate
controls with KLH. Seven days after immunization, we did not
detect any defect in Tfh cells or PNA+ germinal-center B cells
in the IL-4-, IFN-g-, STAT6-, or STAT4-deficient animals com-
pared to wild-type controls (Figures 2B–2D, Figures S4A–S4C).
To confirm the above results, we also measured cytokine secre-
tion of purified CXCR5+ cells from IL-4- and IFN-g-deficient mice
and their controls after they were activated ex vivo with anti-CD3
and anti-CD28 for 24 hr. Tfh cells from IL-4- or IFN-g-deficient
mice produced similar amounts of IL-21 but did not express
IL-4, IL-10, IFN-g, or IL-17 (Figure S4D), suggesting that they
were Tfh cells. Thus, we conclude that CXCR5+CD4+ Tfh cells
develop independently of the Th1 and Th2 cell lineages.
ICOSL Expressed on B Cells Regulates
the Generation of Tfh Cells
Inducible costimulator (ICOS) is the third member of the CD28
family with an important role in regulation of T-dependant Ab
responses and germinal-center reactions (Dong and Nurieva,Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 139
Immunity
Regulation of Tfh Cell DevelopmentFigure 1. Tfh Cells Express Genes Distinct from those Expressed by Th1, Th2, and Th17 Cells
C57BL/6 mice were immunized with KLH in CFA. Seven days later, CD4+CD44hiCXCR5+ BTLA+ (Tfh) cells were sorted and restimulated with anti-CD3 for 4 hr for
gene profiling analysis (A) and for real-time PCR analysis (B). OT-II T cells differentiated under various conditions were restimulatedwith anti-CD3 for 4 hr andwere
analyzed together with Tfh cells.
(A) A distinct gene expression profile of Tfh cells from Th1, Th2, and Th17 cells. Hierarchical clustering and PCA were applied to the expression levels of 8350
probe sets showing differential expressions among the four types of cells (FDR = 0.1, corresponding to an unadjusted p value = 0.033 from one-way ANOVA).
(B) Real-time RT-PCR analysis of Th-specific genes. The graph shows means ± standard deviation (SD).
(C and D) CD4+CD44hiCXCR5+ BTLA+ and CD4+CD44hiCXCR5 cells were restimulated with anti-CD3 plus anti-CD28 for 48 hr for cytokine measurement by
ELISA (C) and with PMA and Ionomicin for 6 hr for detection of IL-17 and IFN-g expression by intracellular cytokine staining (D).
In (C) the graph shows means ± SD. The data represent one of two independent experiments with similar results.2003). ICOSwas previously shown to be expressed at high levels
on human tonsillular CXCR5+ T cells within the light zone of ger-
minal centers and efficiently supported the immunoglobulin pro-
duction (Breitfeld et al., 2000; Schaerli et al., 2000). In addition,
ICOS deficiency in human and mouse resulted in substantially
reduced numbers of Tfh cells, indicating an essential role of
ICOS in the differentiation of CXCR5+ CD4 T cells (Akiba et al.,
2005; Bossaller et al., 2006). Consistently, we also observed
reduced percentages of CXCR5+CD4+ cells and decreased ex-
pression of IL-21 but not IFN-g in our ICOSL germline-deficient
(Icosl/) animals (Nurieva et al., 2003b) after KLH immunization
(Figure 3A). Tfh cells are regarded as regulators of the germinal-
center reaction because they help to activated B cells that also140 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.express CXCR5. Because B cells constitutively express ICOSL,
we asked whether the generation of Tfh cells may require B cell
help via engagement of ICOS receptor on T cells. We thus bred
mice carrying the ICOSL conditional flox (f) allele (Nurieva et al.,
2003b) with CD19-cre mice (Rickert et al., 1995). In Icoslf/f mice
carrying the CD19-cre (Icoslf/fCd19Cre+), in comparison to those
without cre expression, there was efficient deletion of the ICOSL
gene in B cells, similar to those in ICOSL germline-deficient mice
(Figure 3B). We then immunized Icoslf/fCd19Cre+ mice with KLH
and found that absence of ICOSL in B cells led to a greatly
reduced frequency of CXCR5+CD4+ cells (Figure 3C). Similarly,
when CD45.1+ OT-II cells were transferred into Icoslf/fCd19Cre+
mice, the numbers of CD45.1
+
Tfh cells were also greatly reduced
Immunity
Regulation of Tfh Cell DevelopmentFigure 2. Generation of Tfh Cells Is Independent of Th1 and Th2 Cell Lineages
(A) CD4+ T cells fromOT-II mice (CD45.2) were transferred into C57BL/6 (CD45.1) mice, which were subsequently divided into two groups (three mice per group).
Mice were immunized subcutaneously with Ova protein emulsified in CFA and treated with a 300 mg of control rat Ig or anti-IFN-g and anti-IL-4 mAbs. Seven days
after the immunization, experimental mice were sacrificed and splenic CD45.1+ and CD45.2+ CD4 cells were stained with biotinylated CXCR5 mAb, followed
by APC-labeled streptavidin. Numbers in dot-plot quadrants represent the percentages. CD44hiCXCR5+ and CD44hiCXCR5 cells from immunized mice were
purified, and real-time RT-PCR analysis of Tfh-specific genes were performed. The graph shows means ± SD.
(B and C) Il4/, Ifng/ (B), Stat6/ (C), and Stat4/ (D) and their appropriate controls (WT, three mice per group) were immunized with KLH emulsified in CFA.
Seven days after the immunization, experimental mice were sacrificed and the germinal-center B cells were determined by staining with FITC-labeled PNA and
PerCP-labeled B220 mAb. The Tfh cells were analyzed by staining with PerCP-labeled CD4 mAb and biotinylated CXCR5 mAb, followed by APC-labeled strep-
tavidin. Numbers in dot-plot quadrants represent the percentages. The experiments were repeated three times with consistent results.after Ova-peptide immunization (data not shown). In addition to
CXCR5 expression, we found that the expression of IL-21 was
also greatly reduced in Icoslf/fCd19Cre+mice, whereas IFN-g ex-
pressionwas elevated in thesemice (Figure 3C).Moreover, PNA+
germinal-center B cells were greatly reduced in these animals
(Figures 3C and 3E). KLH-specific IgG production was also re-
duced (Figure 3D). Overall, these data indicate that B cell expres-
sion of ICOSL is necessary for IL-21 production and for the
generation of Tfh cells and appropriate antibody responses,
indicating that Tfh cell differentiation is regulated by B cells.IL-21 and IL-6 Are Required for Generation
of Tfh Cells, which Is Dependent on STAT3
IL-21 has been recently shown to be induced by IL-6 and to
autoregulate its own expression during Th17 cell differentiation
(Nurieva et al., 2007a). In addition, Tfh T cells produced greater
amount of IL-21 compared to Th1 and Th2 cell subsets
(Chtanova et al., 2004) and induced the differentiation of autolo-
gous B cells into Ig-secreted plasma cells through IL-21 (Bryant
et al., 2007). Because IL-21 is also expressed in Tfh cells, we as-
sessed whether IL-21 is important for Tfh cell generation. Il21+/+,Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 141
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Regulation of Tfh Cell DevelopmentFigure 3. B7H Expressed on B cells Is Required for Generation of Tfh Cells
(A) ICOSL germline-deficient mice (Icosl/) and their controls (WT, three mice per group) were immunized with KLH in CFA. Seven days after the immunization,
experimental mice were sacrificed and spleen cells from immunizedmice were stimulated in 96-well plates as triplicates with the indicated concentration of KLH.
Effector cytokines (IFN-g and IL-21) were measured after 4 days of treatment. The graph shows means ± SD. The germinal-center B cells and Tfh cells were
analyzed. p valueswere calculatedwith the t test by comparison of theCXCR5+ cells andB220+PNA+ cells betweenwild-type and Icosl/mice and are indicated
as follows: *, p < 0.005; #, p < 0.001. Numbers in dot-plot quadrants represent the percentages.
(B) Splenic B220+ B cells from ICOSL germline-deficient mice (Icosl/), B cell-specific ICOSL-deficient mice (Icoslf/fCd19Cre+), and their controls (Icoslf/f) were
analyzed for ICOSL expression.
(C–E) Icoslf/f and Icoslf/fCd19Cre+ mice (three mice per group) were immunized with KLH in CFA. Seven days after the immunization, experimental mice were
sacrificed and analyzed as in (A). The graph shows means ± SD. In (C), p values were calculated with the t test by comparison of the CXCR5+ cells and
B220+PNA+ cells between Icoslf/f and Icoslf/fCd19Cre+ mice and are indicated as follows: **, p < 0.001; ##, p < 0.001. (D) KLH-specific antibodies (IgM and
IgG) were measured in the sera by ELISA. The sera from Icoslf/f and Icoslf/fCd19Cre+ mice were subjected to a 3-fold serial dilution, and the concentrations
of KLH-specific IgM and IgG were analyzed by ELISA and averaged for each group. (E) GC in the spleens of KLH-immunized Icoslf/f and Icoslf/fCd19Cre+
mice were identified by PNA staining (brown). T and B cells were identified by staining with anti-CD4 (red) and anti-B220 (blue). The data represent at least three
independent experiments with consistent results.Il21+/, and Il21/ mice were immunized with KLH, and splenic
Tfh cells were analyzed in thesemice. Il21+/mice exhibited a re-
duced number of Tfh cells, which was further reduced in Il21/
mice (Figure 4A). In addition, PNA+ germinal-center B cells were
also greatly reduced in Il21/ mice (Figures 4B and 4C). In con-
trast, CD4 T cells from Il21+/ and Il21/ mice showed normal
proliferation and IFN-g expression after restimulation with KLH
ex vivo (Figure 5D). Thus, these results indicate that IL-21 is
necessary for Tfh cell development.
Because IL-6 induces IL-21 expression, we also tested Tfh cell
generation in mice lacking IL-6. It has been previously shown142 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.that IL-6-deficient mice showed reduced germinal centers and
antigen-specific Ig production (IgG) (Kopf et al., 1998). Com-
pared to the wild-type controls, Il6/ mice exhibited greatly
reduced numbers of Tfh cells and germinal-center B cells
(Figure 5A), indicating that IL-6 is also necessary for Tfh cell
generation.
Because Tfh cells expressed high amounts of IL-21R, IL-6R,
and IL-6st (Figure 1B), we also examined whether IL-6 and
IL-21 signaling regulates Tfh cells. C57BL/6 mice were immu-
nized with KLH, and CD4+CD44hi T cells with or without CXCR5
expression were FACS sorted and restimulated with anti-CD3
Immunity
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pared to non-Tfh cells, CXCR5+ T cells showed a substantial
reduction in proliferation when activated with anti-CD3 and
anti-CD28. Treatment of CXCR5+ T cells with IL-6 or IL-21 signif-
icantly enhanced their proliferation (p < 0.005) (Figure 5B), sug-
gesting that IL-6 and IL-21 preferentially regulate Tfh cells. Fur-
thermore, we stained restimulated CXCR5+ and CXCR5 cells
with Annexin V. We found that a substantial portion of CXCR5+
cells underwent apoptosis compared to CXCR5 (Figure 5B).
However, IL-6 or IL-21 treatment reduced apoptosis of Tfh cells.
Because both IL-6 and IL-21 signal through STAT3, we ana-
lyzed Tfh cell generation in Stat3f/f mice (Takeda et al., 1999)
bred with CD4-cre mice (Lee et al., 2001). The deletion of
STAT3 gene in CD4+ thymocytes was found to be complete
(data not shown). When we immunized these mice as well as
their controls with KLH, the numbers of CXCR5+ Tfh cells were
found to be greatly reduced in the absence of STAT3
(Figure 5C). Moreover, STAT3 deficiency in T cells also led to
defective germinal-center B cell generation (Figure 5C). KLH-
specific IgG and IgM production was also reduced in the ab-
sence of STAT3 in T cells (Figure S5). Overall, these data indicate
that Tfh cell generation is dependent on IL-21, IL-6, and STAT3.
Tfh Cell Generation Is Independent of Th17
Cell Differentiation or Function
The above results indicate that the IL-6-IL-21 axis and STAT3
transcription factor are necessary for Tfh cell generation, which
Figure 4. IL-21 Is Necessary for Tfh Cell Devel-
opment
Il21+/+, Il21+/, and Il21/mice (three mice per group)
were immunized subcutaneously with KLH emulsified
in CFA. Seven days after the immunization, experi-
mental mice were sacrificed and Tfh cells (A) and the
germinal-center B cells (B) were analyzed. Numbers
in dot-plot quadrants represent the percentages.
Germinal centers were determined by immunohisto-
chemical analysis (C). Spleen cells from immunized
mice were stimulated in 96-well plates as triplicates
with the indicated concentration of KLH peptide (D).
Proliferation was assayed after 3 days of treatment
by adding [3H]thymidine to the culture for the last 8
hr. IFN-g was measured after 4 days of treatment.
The graph shows means ± SD. The experiments
were repeated twice with consistent results.
is similar to the regulation of Th17 cell differ-
entiation. To test whether the development
of Tfh cells is dependent on or independent
of the Th17 cell lineage, we utilized Rag1/
mice reconstituted with bone-marrow cells
from wild-type, Rorast/st, or Rorast/stRorc/
mice. We recently reported that the latter
mice were completely impaired in Th17 cell
differentiation in vitro and in vivo (Yang
et al., 2008b). However, upon KLH immuni-
zation, these mice deficient in both RORa
and RORg in lymphocytes developed more
CXCR5+ cells in spleen (Figure 6A), indicat-
ing that Tfh cells can be generated in the
absence of Th17 cell development. Moreover, PNA+ germinal-
center B cells were not affected in these animals (Figure S6B).
Because Th17 cell differentiation requires also TGF-b in addi-
tion to IL-6 or IL-21, we examined whether TGF-b signaling is re-
quired for Tfh cell generation. C57BL/6 mice were immunized
with KLH in the absence or presence of TGF-b blocking antibody
as previously described (Veldhoen et al., 2006b). Whereas IL-17
expression was substantially decreased in anti-TGF-b-treated
mice, CXCR5 expression was not (Figure 6B), indicating that
TGF-b signaling is not essential for Tfh cell generation. Moreover,
PNA expression on B cells was not affected either (Figure 6B).
To understand whether Tfh cell generation requires Th17 cell
function, we also immunized mice deficient in IL-17 or IL-17F.
Lack of IL-17 or IL-17F did not substantially reduce the number
of Tfh cells in spleen or the number of germinal-center B cells
(Figure 6C, Figure S6B). IL-17 or IL-17F is thus not essential in
the generation of Tfh cells in vivo.
IL-21 in the Absence of TGF-b Initiates
Tfh Cell Differentiation
Our results thus far suggest that although IL-6 and IL-21 are
required for both Tfh and Th17 cell differentiation, these two sub-
sets appear to have distinct genetic programs and differ in their
dependency on TGF-b signaling. We next assessed whether
IL-21 is sufficient to drive Tfh cell development in vitro in the ab-
sence of TGF-b signaling. Naive OT-II cells were activated by
Ova peptide and splenic APCs in the absence (neutral condition)Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 143
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Il6/ (A) or T cell-specific Stat3/ mice (C) and their appropriate controls (WT, three mice per group) were immunized subcutaneously with KLH emulsified in
CFA. Seven days after the immunization, experimental mice were sacrificed and Tfh cells and the germinal-center B cells were analyzed. Numbers in dot-plot
quadrants represent the percentages.
(B) C57BL/6 mice were immunized with KLH in CFA. Seven days later, CD4+CD44hiCXCR5+ and CD4+CD44hiCXCR5 cells were sorted and restimulated with
anti-CD3 and anti-CD28 with or without IL-6 or IL-21 for 48 hr. Proliferation was assayed by adding [3H]-thymidine to the culture for the last 8 hr. The graph shows
means ± SD. p values were calculated with the t test by comparison of the CXCR5+ cells proliferation in the absence and in the presence of IL-6 (*, p < 0.005) or
in the absence and in the presence of IL-21 (*, p < 0.005). CD4+CD44hiCXCR5+ and CD4+CD44hiCXCR5 cells were restimulated with anti-CD3 and anti-CD28
for 24 hr and stained with Annexin V-FITC. The experiments were performed two times with consistent results.or presence of IL-21, TGF-b, and antibodies to IL-4 and IFN-g
(Th17 cell condition) or IL-21 plus antibodies to IL-4, IFN-g,
and TGF-b. Five days later, the activated T cells were extensively
washed and restimulated with anti-CD3 for 4 hr, and their gene
expression was assessed by real-time RT-PCR. As expected,
cells cultured under Th17 condition highly expressed TH17-
specific genes, including genes encoding IL-17, IL-17F, IL-22,
RORa, and RORgt (Figure 7A). In contrast, T cells treated with
IL-21 in the absence of TGF-b signaling upregulated genes
that are specifically expressed in Tfh cells, including those
encoding CXCR5, Bcl-6, IL-6R, and IL-6st (Figure 7A). They
also upregulated IL-21R expression but did not express Th17
genes (Figure 7A). The gene encoding PD-1 was also highly ex-
pressed in these cells (data not shown). To confirm this result, we
measured cell supernatants 24 hr after restimulation for cytokine
secretion by ELISA. IL-21 in the absence of TGF-b signaling did144 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.not support IL-17 expression, but the resulting cells expressed
high levels of IL-21 (Figure 7B), suggesting that IL-21 expression
is independent of TGF-b signaling.
To test the function of these Tfh-like cells in vivo, we trans-
ferred OT-II cells (CD45.1+) activated under neutral condition
or with IL-21 plus blocking antibodies to IFN-g, IL-4, and
TGF-b into recipient mice (CD45.2+), followed by immunization
with Ova protein. Compared to mice receiving no cells or T cells
activated under neutral condition, the recipients of IL-21-treated
cells exhibited greatly increased CD45.1+ Tfh cells (Figure 7C).
Interestingly, host T cells in these mice also had approximately
four times the Tfh cells of those receiving T cells activated under
neutral condition (Figure 7C). The transferred cells also pro-
moted Ova-specific antibody production and germinal-center
reactions (Figures 7D–7F). As a control for the above experiment,
we sorted CD45.1+ CXC5+CD44hi cells from KLH-immunized
Immunity
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Rag1/ reconstituted with WT and Rorast/st/Rorc/ bone-marrow cells (A) or Il17/ and Il17f/mice and their controls (C) (three mice per group) were immu-
nized subcutaneously with KLH in CFA. Seven days after the immunization, experimental mice were sacrificed and the Tfh cells (A and C) and germinal-center B
cells (C) were determined. Numbers in dot-plot quadrants represent the percentages.
(B) C57BL/6micewere immunizedwith KLH emulsified in CFAwith 100 mg of isotype control antibodies or TGF-b blocking Abs (threemice per group). Seven days
later, experimental mice were sacrificed and splenic Tfh cells and germinal-center B cells were analyzed. Splenocytes were restimulated with KLH overnight, and
the production of IL-17 and IFN-g was analyzed in CD4+ gate by intracellular cytokine staining. The results represent one of three individuals with similar results.mice and transferred them into recipient mice (CD45.2+), fol-
lowed by immunization with KLH. Similar to in vitro-generated
Tfh cells, in vivo-generated CXCR5+ cells also promoted a sub-
stantial increase in PNA+ germinal-center B cells (Figure 7G).
These results indicate that IL-21, in the absence of Th1, Th2,
and Th17 cell differentiation, drives Tfh cell development.
DISCUSSION
Although strongly implicated in antibody production and germi-
nal-center reactions, the ontogeny of Tfh cells has been unclear.
In the current study, we find that Tfh cells are distinct from Th1,
Th2, or Th17 cells in their gene expression and developmental
regulation. Generation of Tfh cells requires IL-21, IL-6, and
STAT3.
Although implicated in humoral immunity and antibody-medi-
ated autoimmunity, the regulation of Tfh cell development is un-
clear. ICOS-ICOSL interaction has been well established in the
literature to regulate humoral immunity and germinal-center re-
actions (Dong and Nurieva, 2003). This costimulatory pathway
was also found to be important in the generation of Tfh cells in
mouse (Akiba et al., 2005). Interestingly, ICOS deficiency in
human patients also causes a severe reduction of Tfh cells(Bossaller et al., 2006). Conversely, impaired negative regulation
of ICOS by Roquin E3 ubiquitin ligase led to increased numbers
of CXCR5+ Tfh cells and IL-21 hyperproduction (Vinuesa et al.,
2005a; Yu et al., 2007). However, the mechanism by which
ICOS and ICOSL regulate Tfh cell development has not been
clear. In our current study, we find that the ICOS-B7h interaction
is necessary for IL-21 expression by T cells. ICOS may thus reg-
ulate Tfh cells through production of IL-21. A recent study by Kim
et al. has revealed IL-21 regulation by calcium signaling and
NFAT factors (Kim et al., 2005). We previously showed that
ICOS, together with TCR and CD28, increases the expression
of NFATc1 through a PI-3 kinase-Itk-calcium pathway (Nurieva
et al., 2003a, 2007b). ICOS may act through NFATc1 to regulate
IL-21 expression. Given that IL-21 also regulates Th17 cell differ-
entiation, an IL-21 defect may account for the impairment in
IL-17 expression in the ICOS-deficient animals (Dong and
Nurieva, 2003). Moreover, using a B cell-specific ICOSL-
deficient mouse, we show that ICOSL expression on B cells is
required for the generation of Tfh cells and IL-21 expression.
This result not only substantiates the importance of ICOS-ICOSL
interaction in Tfh cell development but also suggests an impor-
tant function of B cells in vivo as APCs in the generation or
maintenance of Tfh cells. Consistent with our findings, EbertImmunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 145
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Regulation of Tfh Cell DevelopmentFigure 7. IL-21, in the Absence of IL-4, IFN-g, and TGF-b Signaling, Generates Tfh Cells
(A–F) FACS-sorted CD62hiCD44loCD25CD4+ T cells from CD45.1+ OT-II mice were cultured with irradiated splenic APC plus OVA323-339 peptide under Th0, Tfh
(IL-21 plus antibodies to IL-4, IFN-g, and TGF-b), or TH17 cell condition for 5 days. After 5 days, CD4+ T cells were restimulated with anti-CD3 for 4 hr for real-time
PCR analysis (A) or for 24 hr for cytokine measurement by ELISA (B). In (A) and (B), the graphs showmeans ± SD. (C–F) Five days after in vitro differentiation, cells
were adoptively transferred into CD45.2+ congenicmice (n = 3–4) before the recipient mice were subcutaneously immunizedwith OVA in IFA. A group of mice that
did not receive T cells was used as a control (No transfer). Seven days after immunzation, lymphoid cells from the draining lymph nodes of recipient mice were
isolated and Tfh cells and germinal-center B cells were analyzed (D). Numbers in the boxes represent the percentages. (E) The sera from the recipient mice were
subjected to a 3-fold serial dilution, and the concentrations of OVA-specific IgM and IgG were analyzed by ELISA and averaged for each group. The graph shows
means ± SD. (F) Germinal centers in the spleens of the recipient mice were identified by PNA staining (brown). The results are a representative of multiple mice of
two independent experiments with similar results.
(G) CXCR5+CD44hi cells were sorted from CD45.1 mice on day 7 after immunization with KLH and transferred to CD45.2 (n = 3) recipient mice after immunization
with KLH in CFA. A group of mice that did not receive T cells was used as a control (No transfer). Seven days after immunization, germinal centers in the spleens of
the recipient mice were identified by PNA staining (brown).et al. previously showed that human B cells regulate Tfh cell
phenotypes (Ebert et al., 2004).
Previous gene expression analysis has revealed that human
Tfh cells are distinct from Th1 and Th2 cells (Chtanova et al.,
2004); (Kim et al., 2004). Our current study also reveals that Tfh
cells do not produce Th1 or Th2 cell cytokines. Interestingly, al-
though human Tfh cells appear to express IL-10 and CXCL13,
a ligand for CXCR5 (Chtanova et al., 2004; Ebert et al., 2004;
Kim et al., 2001, 2004), mouse Tfh cells do not. What accounts
for this species difference would need further investigation.
Moreover, we found that naive T cells differentiate into Tfh cells
in vivo, which is independent of IFN-g, IL-4, and STAT6. From146 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.these data, we conclude that Tfh cells develop independent of
Th1 and Th2 cell lineages.
On the other hand, Tfh cells share common regulators with
Th17 cells. Both subsets express IL-21, and their development
depends similarly on IL-6, IL-21, and STAT3. However, Tfh cells
differ from Th17 cells in the following aspects. First, they are dis-
tinct in their gene expression profiles. Second, Tfh cells do not
produce IL-17, IL-17F, or IL-22. Most importantly, Tfh cell devel-
opment does not require RORa or RORgt. Thus, we believe that
Tfh cells develop independently of the Th17 cell lineage. Th17
cell development in mouse is not only mediated by the IL-6-IL-21
axis, but also by TGF-b. We show here that IL-21 can be induced
Immunity
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the presence of IL-21 but in the absence of IL-4, IFN-g, and
TGF-b signaling produced IL-21 but not IL-4, IFN-g, IL-17, IL-
17F, or IL-22. Furthermore, these cells acquired expression of
CXCR5, Bcl-6, IL-6R, and IL-6st, genes that were expressed
by in vivo generated Tfh cells, suggesting that Tfh cells may be
generated in vitro under the above condition. Moreover, these
Tfh-like cells generated in vitro preferentially expressed CXCR5
and functioned to promote humoral immunity, similar to in
vivo-generated Tfh cells. Furthermore, TGF-b signaling, al-
though required for IL-17 expression in vivo, is not essential for
Tfh cells, indicating a reciprocal relationship of Tfh and Th17
cells. Interestingly, Bcl-6 has recently been shown as a repressor
of TGF-b-SMAD signaling (Wang et al., 2008), suggesting that
lack of TGF-b signaling may favor Tfh cell development. These
results further indicate that Tfh cell development is independent
of Th1, Th2, and Th17 cells, and IL-21 serves as critical factor for
generation of this lineage. Interestingly, in vitro-generated Tfh
cells also enhanced the Tfh cell generation in recipientmice, sug-
gesting that IL-21 may function in a paracrine fashion to regulate
Tfh cell development.
In summary, our current study has extensively characterized
the developmental regulation of Tfh cells. Our data indicate
that Tfh cells are distinct in their gene expression and immune
function and develop via a pathway that is dependent on IL-21
or IL-6 but independent of Th1, Th2, or Th17 cell lineages
(Figure S7). In mice defective in Tfh cells, there existed still-
detectable amounts of antigen-specific antibodies, suggesting
that other Th cell subsets may independently regulate the
humoral immunity. This knowledge may help us to find ways to
treat antibody-mediated autoimmune diseases.
EXPERIMENTAL PROCEDURES
Mice
IL-4-, IFN-g-, and IL-6-deficient mice on C57BL/6 background and STAT6-
and STAT4-deficient mice on BALB/c background were purchased from Jack-
son Laboratories, and C57BL/6, B6.SJL (CD45.1) and BALB/c mice were used
as controls. Rorast/st, Rorast/st Rorc/ , and wild-type bone-marrow chimeras
were generated as described (Yang et al., 2008b). Stat3f/f mice (Takeda et al.,
1999) were bred with CD4-Cre mice provided by C. Wilson (Lee et al., 2001).
IL-21-deficient mice on 129xC57BL/6 F1 mixed background were obtained
from the National Institutes of Health (NIH) Mutant Mouse Regional Resource
Centers (MMRRC) (Nurieva et al., 2007a). Icoslf/fCd19Cre+ mice were created
by breeding ICOSL flox mice (Nurieva et al., 2003b) with CD19-cre mice
(Rickert et al., 1995). IL-17- and IL-17F-deficient mice were recently generated
in our lab (Yang et al., 2008a). Mice were housed in the specific pathogen-free
(SPF) animal facility at M.D. Anderson Cancer Center, and the animal experi-
ments were performed at the age of 6–10 weeks with protocols approved by
Institutional Animal Care and Use Committee.
T Cell Differentiation
Differentiation of OT-II cells in Figures 1A and 1B was performed as previously
described (Chung et al., 2006). In Figure 7A, the cytokine stimuli for Th17 cell
differentiation were as follows: 100 ng/ml IL-21, 5 ng/ml TGF-b, 10 mg/ml anti-
IL-4, and 10 mg/ml anti-IFN-g, and for generation of Tfh cells were 50 ng/ml
IL-21, 10 mg/ml anti-IFN-g, 10 mg/ml anti-IL-4, and 20 mg/ml TGF-b (1D11) neu-
tralizing Abs. IL-4, IL-6, IL-12, and TGF-b were purchased from Peprotech.
IL-21, IL-23, and TGF-b (1D11) neutralizing Abs were purchased from R&D.
For characterization of the in vitro-differentiated CD4+ T cells under these con-
ditions, these cells were restimulated with plate-bound anti-CD3 (5 mg/ml) for
4 hr for real-time PCR analysis, or for 24 hr for cytokine measurement by
ELISA.Keyhole Limpet Hemocyanin Immunization
Various strains of mice (6–8 wk old; three per group) were immunized with KLH
(0.5 mg/ml) emulsified in CFA (0.5 mg/ml) at the base of the tail (100 ml each
mouse). In Figure 6, for local blockade of TGF-b, 100 mg anti-TGF-b (1D11)
was included in the emulsion; the control group received 100 mg isotype con-
trol antibodies. Seven days after immunization, thesemice were sacrificed and
analyzed individually. The germinal-center B cells were determined by staining
with FITC-labeled PNA (PharMingen) and PerCP-labeled anti-B220 mAb
(PharMingen). The Tfh cell induction was determined by staining with
PerCP-labeled anti-CD4 mAb (PharMingen) and biotinylated anti-CXCR5
mAb (PharMingen), followed by APC-labeled streptavidin (Jackson Immuno-
Research Laboratories). In some experiments, antigen-specific IgM antibodies
and IgG antibodies in sera from immunizedmice weremeasuredwith ELISA. In
brief, serum samples were added in a 3-fold serial dilution onto plates pre-
coated with 10 mg/ml KLH or Ova protein. Antigen-specific antibodies were
detected with biotinylated goat anti-mouse IgM or rat anti-mouse IgG anti-
bodies (Southern Biotechnology Associates). For analysis of the role of ICOSL
in regulation of T cell responses in vivo (Figures 3A and 3C), spleen cells from
KLH-immunized mice were stimulated in 96-well plates as triplicates with or
without KLH. Effector cytokines (IFN-g and IL-21) were analyzed 4 days later
by ELISA (PharMingen). In Figure 6B, spleen cells from immunized mice
were restimulated with 50 mg KLH for 24 hr. In the final 5 hr, Golgi-stop (BD Bio-
science) was added, and IL-17- and IFN-g-producing cells were analyzed with
a BD CytoFix/CytoPerm intracellular staining kit (BD Bioscience).
Statistical Analysis of Microarray Data
The DNA microarray analysis was carried out at the Institute for Systems Biol-
ogymicroarray core facility with AffymetrixMouse 430 2.0 chips. The total RNA
samples were labeled according to the manufacturer’s instruction by the One-
Cycle Target Labeling method, which consists of oligo-dT-primed cDNA
synthesis followed by in vitro transcription that incorporates biotinylated nu-
cleotides. The microarray data were normalized with GCRMA (Wu et al.,
2004). We then selected the genes whose expression was changed across
the Th1, Th2, Th17, and Tfh cells by using a false-discovery rate (FDR) estima-
tion method (Storey and Tibshirani, 2001): (1) one-way ANOVA was performed
to compute unadjusted p value for the four classes of cells; (2) the number of
nondifferentially expressed probe sets (m0) was estimated as 2 3 the number
of the probe sets with p value > 0.5 (m0 = 25088); (3) the expected number of
false positives under the complement null hypothesis E(V0) was estimated for
a given ANOVA F statistic value by resampling 500 times; and (4) FDR was
finally estimated as m0/m 3 E(V0)/R where m is the total number of the probe
sets (m = 45037) and R is the number of the genes being selected with the
given ANOVA F statistic value (FDR estimated for various F statistic value is
shown in Figure S2B). Then, the expression of 8350 probe sets showing differ-
ential expressions among the four types of cells (FDR = 0.1, corresponding to
an unadjusted p value = 0.033 from one-way ANOVA) was used for hierarchical
clustering (Euclidian distance metric andWard minimum variance linkage) and
PCA.
Adoptive-Transfer Study
CD4+ T cells from OT-II mice (CD45.2) were intravenously transferred into
C57BL/6 (CD45.1+) mice (3 3 106 cells/mouse) (three groups; three mice per
group). Two groups of recipient mice were immunized subcutaneously with
100 mg Ova protein emulsified in CFA and treated with a 300 mg of control
rat Ig or anti-IFN-g and anti-IL-4 mAbs at the time of immunization (day 0)
and on days 2 and 4. Seven days after the immunization, experimental mice
were sacrificed and splenic CD45.1+ and CD45.2+ CD4 cells were stained
with biotinylated anti-CXCR5 mAb, followed by APC-labeled streptavidin. In
Figures 7C–7E, FACS-sorted naive (CD4+CD62LhiCD44CD25) T cells from
CD45.1+ OT-II mice were activated under TH0 or Tfh condition, washed, and
intravenously transferred into C57BL/6 (CD45.2+) mice (4 3 106 cells/mouse),
and the recipient mice were subcutaneously immunized with 100 mg OVA pro-
tein emulsified in IFA. A group of C57BL/6 mice that did not receive T cells was
used as a control (no transfer). In Figure 7G, CXCR5+CD44hi cells were sorted
from B6.SJL (CD45.1) mice immunized with KLH. These cells were transferred
into C57BL/6 (CD45.2+) mice (53 106 cells/mouse) (threemice per group). The
second group did not receive cells. All mice were immunized subcutaneously
with 1000 mg KLH. Seven days after immunzation, lymphoid cells from theImmunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 147
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FITC-labeled anti-CD45.1mAb and PerCP-labeled anti-CD4mAb plus biotiny-
lated anti-CXCR5, followed by APC-labeled streptavidin, or stained with
FITC-labeled PNA and PerCP-labeled anti-B220.
Quantitative Real-Time PCR
Total RNA was prepared from T cells with TriZol reagent (Invitrogen). cDNA
were synthesized with Superscript reverse transcriptase and oligo(dT) primers
(Invitrogen), and gene expression was examined with a Bio-Rad iCycler Opti-
cal System with iQ SYBR green real-time PCR kit (Bio-Rad Laboratories). The
data were normalized to b-actin reference. The following primer pairs for Bcl-6,
IL-6R, IL-6st, and CXCR5 was used: Bcl6 forward: 50-CACACCCGTCCAT
CATTGAA-30, reverse: 50-TGTCCTCACGGTGCCTTTTT-30; IL6R forward: 50-
GGTGGCCCAGTACCAATGC-30, reverse: 50-GGACCTGGACCACGTGCT-30;
CXCR5 forward: 50-ACTCCTTACCACAGTGCACCTT-30, reverse: 50-GGAAAC
GGGAGGTGAACCA-30; IL-6st forward: 50-ATTTGTGTGCTGAAGGAGGC-30,
reverse: 50-AAAGGACAGGATGTTGCAGG-30. The primers for IL-21, IL-17,
IL-17F, IL-4, IFN-g, RORg, RORa, T-bet, GATA3, and b-actin were previously
described (Yang et al., 2007).
Immunohistochemical Analysis
Fresh mouse spleen tissues were embedded in OCT and frozen with isopen-
tane in Histobath. Tissue blocks were sliced 6 mm with cryotome. Slides
were fixed with acetone cold. Purified anti-mouse CD4 or biotin-labeled
anti-mouse PNA were applied as primary Ab followed by biotinylated anti-rat
secondary Ab and avidin-peroxidase complex reagent. Novared was used
as substrate. For double staining, biotin-labeled B220 was applied and fol-
lowed by avidin-aklinphosphotase complex reagent. Vector blue was used
as substrate. CD4 and B220 are from BD Pharmagen. PNA and other reagent
are from Vector Laboratary. Slides for PNA staining were count stained with
Hematoxlin.
ACCESSION NUMBERS
The microarray data have been deposited into NCBI GEO with the accession
number GSE11924.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and can be found with this article
online at http://www.immunity.com/cgi/content/full/29/1/138/DC1/.
ACKNOWLEDGMENTS
We thank B.Marzolf in Institute for SystemsBiology for his assistance inmicro-
array analysis, R. Rickert and R. Carter for the CD19-cremice, C.Wilson for the
CD4-cre mice, Y. Wang for advice, and the Dong lab members for their help.
The work is supported by research grants from the NIH (to C.D.), an Intramural
Research Program of the National Institute of Environmental Health Sciences
(NIEHS, NIH) (to A.M.J.), the Leukemia & Lymphoma Society (to C.D.), and the
MD Anderson Cancer Center (to C.D. and S.S.W.) and the Gillson Longen-
baugh Foundation (to S.S.W.). R.N. is a recipient of a Scientist Development
Grant from the American Heart Association. C.D. is a Trust Fellow of the MD
Anderson Cancer Center, a Cancer Research Institute Investigator, and an
American Lung Association Career Investigator.
Received: January 25, 2008
Revised: April 14, 2008
Accepted: May 9, 2008
Published online: July 3, 2008
REFERENCES
Akiba, H., Takeda, K., Kojima, Y., Usui, Y., Harada, N., Yamazaki, T., Ma, J.,
Tezuka, K., Yagita, H., and Okumura, K. (2005). The Role of ICOS in the
CXCR5+ Follicular B Helper T Cell Maintenance In Vivo. J. Immunol. 175,
2340–2348.148 Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc.Akimzhanov, A.M., Yang, X.O., and Dong, C. (2007). Chromatin remodeling of
interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper
T cell differentiation. J. Biol. Chem. 282, 5969–5972.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L.,
and Kuchroo, V.K. (2006). Reciprocal developmental pathways for the gener-
ation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238.
Bossaller, L., Burger, J., Draeger, R., Grimbacher, B., Knoth, R., Plebani, A.,
Durandy, A., Baumann, U., Schlesier, M., Welcher, A.A., et al. (2006). ICOS de-
ficiency is associated with a severe reduction of CXCR5+CD4 germinal center
Th cells. J. Immunol. 177, 4927–4932.
Breitfeld, D., Ohl, L., Kremmer, E., Ellwart, J., Sallusto, F., Lipp, M., and
Forster, R. (2000). Follicular B helper T cells express CXC chemokine receptor
5, localize to B cell follicles, and support immunoglobulin production. J. Exp.
Med. 192, 1545–1552.
Bryant, V.L., Ma, C.S., Avery, D.T., Li, Y., Good, K.L., Corcoran, L.M., de Waal
Malefyt, R., and Tangye, S.G. (2007). Cytokine-mediated regulation of human
B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced
by CXCR5+ T follicular helper cells. J. Immunol. 179, 8180–8190.
Chtanova, T., Tangye, S.G., Newton, R., Frank, N., Hodge, M.R., Rolph, M.S.,
and Mackay, C.R. (2004). T follicular helper cells express a distinctive tran-
scriptional profile, reflecting their role as non-Th1/Th2 effector cells that
provide help for B cells. J. Immunol. 173, 68–78.
Chung, Y., Yang, X., Chang, S.H., Ma, L., Tian, Q., and Dong, C. (2006).
Expression and regulation of IL-22 in the IL-17-producing CD4+ T lympho-
cytes. Cell Res. 16, 902–907.
Dong, C. (2008). TH17 cells in development: an updated view of their molecular
identity and genetic programming. Nat. Rev. Immunol. 8, 337–348.
Dong, C., and Flavell, R.A. (2000). Cell fate decision: T-helper 1 and 2 subsets
in immune responses. Arthritis Res. 2, 179–188.
Dong, C., and Nurieva, R.I. (2003). Regulation of immune and autoimmune re-
sponses by ICOS. J. Autoimmun. 21, 255–260.
Ebert, L.M., Horn, M.P., Lang, A.B., andMoser, B. (2004). B cells alter the phe-
notype and function of follicular-homing CXCR5+ T cells. Eur. J. Immunol. 34,
3562–3571.
Haynes, N.M., Allen, C.D.C., Lesley, R., Ansel, K.M., Killeen, N., and Cyster,
J.G. (2007). Role of CXCR5 and CCR7 in follicular Th cell positioning and ap-
pearance of a programmed cell death gene-1high germinal center-associated
subpopulation. J. Immunol. 179, 5099–5108.
Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille,
J.J., Cua, D.J., and Littman, D.R. (2006). The orphan nuclear receptor ROR-
gammat directs the differentiation program of proinflammatory IL-17+ T helper
cells. Cell 126, 1121–1133.
Junt, T., Fink, K., Forster, R., Senn, B., Lipp, M., Muramatsu, M., Zinkernagel,
R.M., Ludewig, B., and Hengartner, H. (2005). CXCR5-dependent seeding
of follicular niches by B and Th cells augments antiviral B cell responses.
J. Immunol 175, 7109–7116.
Kim, C.H., Rott, L.S., Clark-Lewis, I., Campbell, D.J., Wu, L., and Butcher, E.C.
(2001). Subspecialization of CXCR5+ T cells: B helper activity is focused in
a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193,
1373–1381.
Kim, C.H., Lim, H.W., Kim, J.R., Rott, L., Hillsamer, P., and Butcher, E.C.
(2004). Unique gene expression program of human germinal center T helper
cells. Blood 104, 1952–1960.
Kim, H.-P., Korn, L.L., Gamero, A.M., and Leonard, W.J. (2005). Calcium-
dependent activation of interleukin-21 gene expression in T cells. J. Biol.
Chem. 280, 25291–25297.
Kopf, M., Herren, S., Wiles, M.V., Pepys, M.B., and Kosco-Vilbois,M.H. (1998).
Interleukin 6 influences germinal center development and antibody production
via a contribution of C3 complement component. J. Exp. Med. 188, 1895–
1906.
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T.B., Oukka, M.,
and Kuchroo, V.K. (2007). IL-21 initiates an alternative pathway to induce
proinflammatory TH17 cells. Nature 448, 484–487.
Immunity
Regulation of Tfh Cell DevelopmentLaurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank,
R.B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007). Interleukin-2
Signaling via STAT5 Constrains T Helper 17 Cell Generation. Immunity 26,
371–381.
Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W.,
Perez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., et al.
(2001). A critical role for Dnmt1 and DNA methylation in T cell development,
function, and survival. Immunity 15, 763–774.
Mangan, P.R., Harrington, L.E., O’Quinn, D.B., Helms, W.S., Bullard, D.C.,
Elson, C.O., Hatton, R.D., Wahl, S.M., Schoeb, T.R., and Weaver, C.T.
(2006). Transforming growth factor-beta induces development of the T(H)17
lineage. Nature 441, 231–234.
Nurieva, R.I., Duong, J., Kishikawa, H., Dianzani, U., Rojo, J.M., Ho, I., Flavell,
R.A., and Dong, C. (2003a). Transcriptional regulation of th2 differentiation by
inducible costimulator. Immunity 18, 801–811.
Nurieva, R.I., Mai, X.M., Forbush, K., Bevan, M.J., and Dong, C. (2003b). B7h is
required for T cell activation, differentiation, and effector function. Proc. Natl.
Acad. Sci. USA 100, 14163–14168.
Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L.,
Schluns, K., Tian, Q., Watowich, S.S., Jetten, A.M., and Dong, C. (2007a). Es-
sential autocrine regulation by IL-21 in the generation of inflammatory T cells.
Nature 448, 480–483.
Nurieva, R.I., Chuvpilo, S., Wieder, E.D., Elkon, K.B., Locksley, R., Serfling, E.,
and Dong, C. (2007b). A costimulation-initiated signaling pathway regulates
NFATc1 transcription in T lymphocytes. J. Immunol. 179, 1096–1103.
Rickert, R.C., Rajewsky, K., and Roes, J. (1995). Impairment of T-cell-depen-
dent B-cell responses and B-l cell development in CD19-deficient mice.
Nature 376, 352–355.
Schaerli, P., Willimann, K., Lang, A.B., Lipp, M., Loetscher, P., and Moser, B.
(2000). CXC chemokine receptor 5 expression defines follicular homing T cells
with B cell helper function. J. Exp. Med. 192, 1553–1562.
Spolski, R., and Leonard, W.J. (2008). Interleukin-21: Basic biology and impli-
cations for cancer and autoimmunity. Annu. Rev. Immunol. 26, 57–79.
Storey, J.D., and Tibshirani, R. (2001). Estimating the Positive False Discovery
Rate Under Dependence, with Applications to DNAMicroarrays, Volume 2001
(Stanford, CA: Department of Statistics, Stanford University).
Takeda, K., Clausen, B.E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I., and
Akira, S. (1999). Enhanced Th1 activity and development of chronic enteroco-
litis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10,
39–49.Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., and Stockinger, B.
(2006a). TGFbeta in the context of an inflammatory cytokinemilieu supports de
novo differentiation of IL-17-producing T cells. Immunity 24, 179–189.
Veldhoen, M., Hocking, R.J., Flavell, R.A., and Stockinger, B. (2006b). Signals
mediated by transforming growth factor-beta initiate autoimmune encephalo-
myelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol.
7, 1151–1156.
Vinuesa, C.G., Cook, M.C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill,
K.M., Yu, D., Domaschenz, H., Whittle, B., Lambe, T., et al. (2005a). A RING-
type ubiquitin ligase family member required to repress follicular helper T cells
and autoimmunity. Nature 435, 452–458.
Vinuesa, C.G., Tangye, S.G., Moser, B., andMackay, C.R. (2005b). Follicular B
helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5,
853–865.
Wang, D., Long, J., Dai, F., Liang, M., Feng, X.-H., and Lin, X. (2008). BCL6
represses Smad signaling in transforming growth factor-B resistance. Cancer
Res. 68, 783–789.
Yang, X.O., Panopoulos, A.D., Nurieva, R., Chang, S.H., Wang, D., Watowich,
S.S., and Dong, C. (2007). STAT3 regulates cytokine-mediated generation of
inflammatory helper T cells. J. Biol. Chem. 282, 9358–9363.
Yang, X.O., Chang, S.H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.H.,
Schluns, K.S., Broaddus, R.R., Zhu, Z., and Dong, C. (2008a). Regulation of
inflammatory responses by IL-17F. J. Exp. Med. 205, 1063–1075.
Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y.,
Ma, L., Shah, B., Panopoulos, A.D., Schluns, K.S., et al. (2008b). T helper 17
lineage differentiation is programmed by orphan nuclear receptors ROR[alpha]
and ROR. Immunity 28, 29–39.
Yu, D., Tan, A.H., Hu, X., Athanasopoulos, V., Simpson, N., Silva, D.G., Hutloff,
A., Giles, K.M., Leedman, P.J., Lam, K.P., et al. (2007). Roquin represses
autoimmunity by limiting inducible T-cell co-stimulator messenger RNA.
Nature 450, 299–303.
Wu, Z., Irizarry, R.A., Gentleman, R., Martinez-Murillo, F., and Spencer, F.
(2004). Amodel-based background adjustment for oligonucleotide expression
arrays. J. Am. Stat. Assoc. 99, 909–917.
Zhou, L., Ivanov, I.I., Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D.E.,
Leonard, W.J., and Littman, D.R. (2007). IL-6 programs TH-17 cell differentia-
tion by promoting sequential engagement of the IL-21 and IL-23 pathways.
Nat. Immunol. 8, 967–974.Immunity 29, 138–149, July 18, 2008 ª2008 Elsevier Inc. 149
